New Fixed-Dose Artesunate-Mefloquine Formulation against Multidrug-Resistant Plasmodium falciparum in Adults: a Comparative Phase IIb Safety and Pharmacokinetic Study with Standard-Dose Nonfixed Artesunate plus Mefloquine (Q22061804)
Jump to navigation
Jump to search
scientific article
- New fixed-dose artesunate-mefloquine formulation against multidrug-resistant Plasmodium falciparum in adults: a comparative phase IIb safety and pharmacokinetic study with standard-dose nonfixed artesunate plus mefloquine
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | New Fixed-Dose Artesunate-Mefloquine Formulation against Multidrug-Resistant Plasmodium falciparum in Adults: a Comparative Phase IIb Safety and Pharmacokinetic Study with Standard-Dose Nonfixed Artesunate plus Mefloquine |
scientific article |
|
Statements
New Fixed-Dose Artesunate-Mefloquine Formulation against Multidrug-Resistant Plasmodium falciparum in Adults: a Comparative Phase IIb Safety and Pharmacokinetic Study with Standard-Dose Nonfixed Artesunate plus Mefloquine (English)
0 references
New fixed-dose artesunate-mefloquine formulation against multidrug-resistant Plasmodium falciparum in adults: a comparative phase IIb safety and pharmacokinetic study with standard-dose nonfixed artesunate plus mefloquine (English)
0 references
S Looareesuwan
S. Looareesuwan
Looareesuwan
S. Krudsood
N. Tangpukdee
P. Wilairatana
W. Phumratanaprapin
W. Leowattana
K. Chalermrut
S. Ramanathan
V. Navaratnam
P. Olliaro
M. Vaillant
J. R. Kiechel
W. R. J. Taylor
14 June 2010
0 references
September 2010
0 references
54
0 references
3730-3737
0 references
3730-7
0 references
9
0 references
2 references
1 reference